Diaceutics PLC
Research Diaceutics PLC (DXRX) on Bullrun: market cap GBX 16.94B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDXRX
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyGBX
- Market capGBX 16.94B
- Financial periodFY2025
- RevenueGBP 38.44M
- Revenue growth19.5%
- Net incomeGBP 97.00K
- Free cash flow-GBP 5.27M
- Gross margin81.9%
Valuation Snapshot
latest market cap is GBX 16.94B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 38.44M | GBP 97.00K | -GBP 5.27M | 81.9% | 0 | GBP 7.34M | GBP 1.15M | GBP 40.48M |
| FY2024 | GBP 32.16M | -GBP 1.70M | -GBP 3.98M | 87.9% | n/a | GBP 12.74M | GBP 1.06M | GBP 39.86M |
| FY2023 | GBP 23.70M | -GBP 1.75M | -GBP 3.54M | 83.2% | -0.02 | GBP 16.67M | GBP 1.21M | GBP 40.79M |
| FY2022 | GBP 19.50M | GBP 724.00K | GBP 226.00K | 85.8% | 0.01 | GBP 19.84M | GBP 1.33M | GBP 42.51M |
| FY2021 | GBP 13.94M | GBP 561.00K | -GBP 5.03M | 87.7% | 0.01 | GBP 19.68M | GBP 1.56M | GBP 40.65M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-06 | GBX 16.94B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Diaceutics PLC's market cap?
Diaceutics PLC's market capitalization is GBX 16.94B.
What does Diaceutics PLC do?
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories.